Lexeo Therapeutics, Inc. (LXEO) Misses Q1 EPS by 10c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q1 EPS of ($0.99), $0.10 worse than the analyst estimate of ($0.89).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• Amazon's AWS to acquire DuckLabs, maker of DuckDB database
• Dycom Industries (DY) Tops Q2 EPS by 59c, Beats on Revenue
• UBS Reiterates Neutral Rating on Oxford Industries (OXM)